Last reviewed · How we verify
Investigational lipid eye drops
Investigational lipid eye drops is a Small molecule drug developed by Johnson & Johnson Vision Care, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Investigational lipid eye drops |
|---|---|
| Sponsor | Johnson & Johnson Vision Care, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction (PHASE3)
- Next Generation Rocklatan (PHASE2)
- A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China (PHASE3)
- Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma (PHASE4)
- Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop (PHASE1)
- Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension (PHASE1, PHASE2)
- Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
- Tear Lipid Layer Thickness With Emollient Eye Drops (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Investigational lipid eye drops CI brief — competitive landscape report
- Investigational lipid eye drops updates RSS · CI watch RSS
- Johnson & Johnson Vision Care, Inc. portfolio CI
Frequently asked questions about Investigational lipid eye drops
What is Investigational lipid eye drops?
Investigational lipid eye drops is a Small molecule drug developed by Johnson & Johnson Vision Care, Inc..
Who makes Investigational lipid eye drops?
Investigational lipid eye drops is developed by Johnson & Johnson Vision Care, Inc. (see full Johnson & Johnson Vision Care, Inc. pipeline at /company/johnson-johnson-vision-care-inc).
What development phase is Investigational lipid eye drops in?
Investigational lipid eye drops is in Phase 1.